Pfizer, drug companies make 'no commitments' to White House about lowering drug prices

Cheaper pharmaceuticals won’t be on shelves any time soon, says the CEO of Pfizer. That’s despite an executive order signed last month declaring a war on drug prices, which at one point President [...]

How an AI system beat experienced doctors at diagnosing rare diseases

DeepRare, an agentic AI system integrating 40 specialised tools, outperformed medical specialists in identifying rare conditions in a head-to-head study published in Nature. For millions of people wit [...]

8 key drug patents expiring soon — and what it means for the market

Nothing drives down a drug’s price like competition. According the U.S. Food and Drug Administration (FDA), a drug’s wholesale price drops by an average of 39% after just one generic competitor en [...]

Apple commits $500 million over several years to buy US-made rare earth magnets

Apple just announced a commitment of $500 million over several years to buy rare earth magnets from the US-based company MP Materials. These rare earth magnets are used in a number of products, includ [...]

Everwild has reportedly been cancelled amid Xbox layoffs

In today's gaming world, a decade of development can sometimes amount to nothing. Parent company Microsoft has reportedly cancelled Rare's long-in-development project Everwild. The news come [...]

Nanoscope Therapeutics CEO Sulagna Bhattacharya on tackling rare eye diseases

Nanoscope Therapeutics CEO Sulagna Bhattacharya discusses how the company is tackling rare eye diseases [...]

‘AI is tearing companies apart’: Writer AI CEO slams Fortune 500 leaders for mismanaging tech

May Habib, co-founder and CEO of Writer AI, delivered one of the bluntest assessments of corporate AI failures at the TED AI conference on Tuesday, revealing that nearly half of Fortune 500 executives [...]

Will AI revolutionise drug development? Researchers say it depends on how it’s used

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. “Artificial intelligen [...]

Google's AI drug discovery spinoff Isomorphic Labs claims major leap beyond AlphaFold 3

Isomorphic Labs, Google DeepMind's AI medicine startup, has unveiled a new system called "Isomorphic Labs Drug Design Engine" (IsoDDE) that it says doubles AlphaFold 3's accuracy f [...]